RA
CORV

Royce & Associates’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Royce & Associates’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-101,100
Closed -$41K – 1214
2019
Q4 		$41K Sell
101,100
-1,312,375
-93% -$2.18M ﹤0.01% 1060
2019
Q3 		$2.83M Buy
1,413,475
+785,475
+125% +$1.59M 0.03% 628
2019
Q2 		$1.36M Buy
628,000
+145,500
+30% +$372K 0.01% 798
2019
Q1 		$1.52M Hold
482,500
– – 0.01% 800
2018
Q4 		$1.2M Buy
482,500
+227,600
+89% +$758K 0.01% 834
2018
Q3 		$1.02M Buy
+254,900
New +$1.12M 0.01% 914

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return